Belimumab – Uses, Mechanism and Side Effects
Belimumab is a monoclonal antibody used to treat systemic lupus erythematosus and lupus nephritis in adults and children aged 5 and older.
Things worth knowing about "Belimumab"
Belimumab is a monoclonal antibody used to treat systemic lupus erythematosus and lupus nephritis in adults and children aged 5 and older.
What is Belimumab?
Belimumab is a monoclonal antibody belonging to the class of biologics. It is approved for the treatment of systemic lupus erythematosus (SLE) and active lupus nephritis (kidney inflammation caused by lupus). Marketed under the brand name Benlysta, it has received approval from both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). Belimumab can be used in adults and in children from the age of 5 years.
Mechanism of Action
Belimumab selectively inhibits the B-lymphocyte stimulator protein (BLyS), also known as BAFF (B-cell activating factor). This protein plays a key role in the survival, proliferation, and maturation of B-lymphocytes – the immune cells responsible for producing antibodies.
In patients with SLE, BLyS levels are often abnormally elevated, leading to excessive immune activation and the overproduction of autoantibodies that attack the body's own tissues. By blocking BLyS, belimumab reduces the number and activity of these misdirected B-cells, thereby dampening the autoimmune response and helping to prevent organ damage.
Indications
- Systemic lupus erythematosus (SLE): In adults and children aged 5 years and above with active, autoantibody-positive disease that is inadequately controlled despite standard therapy.
- Active lupus nephritis: In adults receiving standard background therapy.
Administration and Dosage
Belimumab is available in two formulations:
- Intravenous infusion (IV): 10 mg/kg body weight, administered in a clinical setting over 1 hour. Initial doses are given at weeks 0, 2, and 4, followed by monthly infusions thereafter.
- Subcutaneous injection (SC): 200 mg once weekly, self-administered by the patient after appropriate training.
The choice of administration route depends on the individual clinical situation and the treating physician's recommendation. Belimumab is always used as an add-on to existing standard therapy, such as hydroxychloroquine, corticosteroids, or immunosuppressants.
Side Effects
As with all biologics, belimumab can cause side effects. Common adverse effects include:
- Upper respiratory tract infections (e.g., common cold, bronchitis)
- Urinary tract infections
- Nausea and diarrhea
- Injection site reactions (with subcutaneous use)
- Infusion-related reactions (with intravenous use)
- Sleep disturbances and depressive episodes (in some cases)
Rare but serious risks include:
- Severe infections, including opportunistic infections
- Increased risk of progressive multifocal leukoencephalopathy (PML)
- Suicidal ideation and psychiatric changes
- Severe hypersensitivity reactions
Contraindications and Precautions
Belimumab should not be used in patients with:
- Known severe hypersensitivity to the active substance
- Active severe infections
- Concurrent use of other biologics or cyclophosphamide (except in lupus nephritis where benefit may outweigh risk, as determined by a physician)
Use during pregnancy should only be considered if the potential benefit outweighs the risk to the fetus. Women of childbearing potential should use effective contraception during treatment and for at least 4 months after the last dose.
References
- European Medicines Agency (EMA): Benlysta (belimumab) – Summary of Product Characteristics and European Public Assessment Report (EPAR). Available at: https://www.ema.europa.eu
- Navarra S et al. – Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. The Lancet. 2011;377(9767):721-731.
- Furie R et al. – Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis. New England Journal of Medicine. 2020;383(12):1117-1128.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryPropylene glycol
Cenobamate
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Belimumab